The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Surgical management versus combination radiotherapy in Gleason score 9-10 prostate cancer.
 
Edward Christopher Dee
No Relationships to Disclose
 
Martin T. King
No Relationships to Disclose
 
Santino Butler
No Relationships to Disclose
 
Zizi Yu
No Relationships to Disclose
 
Sybil Sha
No Relationships to Disclose
 
David Dewei Yang
No Relationships to Disclose
 
Brandon Arvin Virgil Mahal
No Relationships to Disclose
 
Kent William Mouw
Consulting or Advisory Role - EMD Serono; Pfizer
Research Funding - Pfizer
 
Anthony Victor D'Amico
No Relationships to Disclose
 
Paul L. Nguyen
Stock and Other Ownership Interests - Augmenix; Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Boston Scientific; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Janssen Oncology; Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring
 
Vinayak Muralidhar
No Relationships to Disclose